Search Results - "Goldberg Arnold, Renée J"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Cost-effectiveness analysis: should it be required for drug registration and beyond? by Arnold, Renée J. Goldberg

    Published in Drug discovery today (01-11-2007)
    “…Cost-effectiveness analysis (CEA) is applied in situations where trade-offs exist, typically, greater benefit for an increased cost over an alternative therapy…”
    Get full text
    Journal Article
  2. 2

    Pharmacoeconomic review of medical management of persistent asthma by Cheng, Judy W M, Arnold, Renée J Goldberg

    Published in Allergy and asthma proceedings (01-03-2008)
    “…Asthma affects 20 million Americans and causes a substantial loss of productivity. Medications help to increase symptom-free days and improve quality of life…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Clinical implications of chemotherapy-induced diarrhea in patients with cancer by Arnold, Renée J Goldberg, Gabrail, Nashat, Raut, Monika, Kim, Renée, Sung, Jennifer C Y, Zhou, Yonglong

    Published in The Journal of supportive oncology (01-05-2005)
    “…Diarrhea is a common, often dose-limiting toxicity associated with cancer chemotherapy treatment. However, the problem is not well recognized and frequently is…”
    Get more information
    Journal Article
  5. 5

    The Cost-Effectiveness of Argatroban Treatment in Heparin-Induced Thrombocytopenia: The Effect of Early Versus Delayed Treatment by Arnold, Renée J. Goldberg, Kim, Renée, Tang, Boxiong

    Published in Cardiology in review (01-01-2006)
    “…A decision-tree analysis was used to estimate the average cost per patient using the direct thrombin inhibitor argatroban for early treatment (<48 hours after…”
    Get full text
    Journal Article
  6. 6

    Cost of treating an episode of variceal bleeding in a VA setting by Zaman, Atif, Goldberg Arnold, Renée J, Pettit, Krista G, Kaniecki, Diana J, Benner, Kent, Zacker, Christopher, DiCesare, Joseph, Helfand, Mark

    Published in The American journal of gastroenterology (01-05-2000)
    “…OBJECTIVES: The specific aims of this study were to develop a demographic description of a sample of patients presenting with bleeding esophageal varices and…”
    Get full text
    Journal Article
  7. 7

    Cost of treating an episode of variceal bleeding in a VA setting by Zaman, Atif, Arnold, Renée Goldberg J, Pettit, Krista G, Kaniecki, Diana J, Benner, Kent, Zacker, Christopher, DiCesare, Joseph, Helfand, Mark

    Published in The American journal of gastroenterology (01-05-2000)
    “…The specific aims of this study were to develop a demographic description of a sample of patients presenting with bleeding esophageal varices and determine the…”
    Get full text
    Journal Article
  8. 8

    Medical resource use and costs of congestive heart failure after carvedilol use by Najib, Mohammad M, Goldberg Arnold, Renée J, Kaniecki, Diana J, Pettit, Krista G, Roth, David, Antell, Laura, Xuan, Jianwei

    Published in Heart disease (Hagerstown, Md.) (01-03-2002)
    “…A retrospective cohort study based on claims and medical chart data was conducted to compare healthcare use and costs in congestive heart failure patients with…”
    Get more information
    Journal Article
  9. 9

    Use of a decision-analytic model to support the use of a new oral US contrast agent in patients with abdominal pain by Bree, R L, Arnold, R J, Pettit, K G, Kaniecki, D J, O'haeri, C, LaFrance, N D, Toaff, A L

    Published in Academic radiology (01-03-2001)
    “…The authors performed this study to compare the cost and diagnostic abilities of ultrasound (US) performed with and without the use of an oral contrast…”
    Get more information
    Journal Article
  10. 10

    Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis by Arnold, Renée J Goldberg, Donnelly, Ann, Altieri, Leah, Wong, Ken S, Sung, Jennifer

    Published in Managed care interface (01-02-2007)
    “…The objective of this study was to assess the consequences of atopic dermatitis/ eczema on two areas: (1) the quality of life of parents/caregivers and (2)…”
    Get more information
    Journal Article
  11. 11

    Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection by Quenzer, R W, Pettit, K G, Arnold, R J, Kaniecki, D J

    Published in The American journal of managed care (01-07-1997)
    “…An interactive pharmacoeconomic model was designed to evaluate the effects of clinical response and adverse drug events on the comparative cost and…”
    Get full text
    Journal Article
  12. 12

    Selection of oral controlled-release drugs: a critical decision for the physician by Arnold, R J, Kaniecki, D J

    “…Controlled-oral release dosage formulations of medications have become relatively prevalent in medicine today because of their ability to reduce noncompliance…”
    Get more information
    Journal Article
  13. 13

    Integrating worldwide marketing needs and clinical research by Kaniecki, D J, Arnold, R J

    Published in Journal of clinical pharmacology (01-10-1993)
    “…In this era of globalization, expanding research needs, and the necessity of sharing global technologies and worldwide data evaluation techniques, a…”
    Get more information
    Journal Article
  14. 14

    Review of the development, validation, and application of predictive instruments in interventional cardiology by Goldberg Arnold, R J, Akhras, K S, Chen, C, Chen, S, Pettit, K G, Kaniecki, D J

    Published in Heart disease (Hagerstown, Md.) (01-07-1999)
    “…Within the last few years, risk assessment has become an integral part of clinical practice, particularly for thoracic surgery and interventional procedures…”
    Get more information
    Journal Article
  15. 15

    Cost-effectiveness of antihypertensive agents in patients with reduced left ventricular function by Arnold, R J, Kaniecki, D J, Frishman, W H

    Published in Pharmacotherapy (01-03-1994)
    “…A pharmacoeconomic primer reviews current economic models used to analyze and synthesize information that may be considered in certain health-related policies…”
    Get more information
    Journal Article
  16. 16

    Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine by Podrid, Philip J., Kowey, Peter R., Frishman, William H., Goldberg Arnold, Renée J., Kaniecki, Diana J., Beck, J.Robert, Beshansky, Joni R.

    Published in The American journal of cardiology (15-12-1991)
    “…Quinidine and procainamide have the potential for major organ toxicity, whereas mexiletine has been reported to have little risk of organ toxicity, serious…”
    Get full text
    Journal Article